Search

Author/Creator Peng, Alice

1. A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients. Issue 2 (February 2015)

Authors:
Vo, Ashley A.; Zeevi, Adriana; Choi, Jua; Cisneros, Kristen; Toyoda, Mieko; Kahwaji, Joseph; Peng, Alice; Villicana, Rafael; Puliyanda, Dechu; Reinsmoen, Nancy; Haas, Mark; Jordan, Stanley C.
Journal:
Transplantation
Issue:
Volume 99:Issue 2(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients. Issue 11 (November 2015)

Authors:
Vo, Ashley A.; Choi, Jua; Kim, Irene; Louie, Sabrina; Cisneros, Kristen; Kahwaji, Joseph; Toyoda, Mieko; Ge, Shili; Haas, Mark; Puliyanda, Dechu; Reinsmoen, Nancy; Peng, Alice; Villicana, Rafael; Jordan, Stanley C.
Journal:
Transplantation
Issue:
Volume 99:Issue 11(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase I/II, double‐blind, placebo‐controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients. Issue 12 (14th May 2018)

Authors:
Jordan, Stanley C.; Choi, Jua; Aubert, Olivier; Haas, Mark; Loupy, Alexandre; Huang, Edmund; Peng, Alice; Kim, Irene; Louie, Sabrina; Ammerman, Noriko; Najjar, Reiad; Puliyanda, Dechu; Vo, Ashley
Journal:
American journal of transplantation
Issue:
Volume 18:Issue 12(2018)
Page Start:
2955
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Assessment of humoral and cellular immune responses to SARS CoV‐2 vaccination (BNT162b2) in immunocompromised renal allograft recipients. Issue 2 (3rd March 2022)

Authors:
Zhang, Ruan; Shin, Bong‐Ha; Gadsden, Terry‐Ann M.; Petrosyan, Anna; Vo, Ashley; Ammerman, Noriko; Sethi, Supreet; Huang, Edmund; Peng, Alice; Najjar, Reiad; Atienza, Janet; Kim, Irene; Jordan, Stanley C.
Journal:
Transplant infectious disease
Issue:
Volume 24:Issue 2(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL) TREATMENT OF PATIENTS WITH CHRONIC & ACTIVE ANTIBODY-MEDIATED REJECTION POST-KIDNEY TRANSPLANTATION (NCT03380377). Issue 3 (September 2020)

Authors:
Jordan, Stanley; Ammerman, Noriko; Toyoda, Mieko; Ge, Shili; Huang, Edmund; Peng, Alice; Sethi, Supreet; Najjar, Reiad; Ortiz, Edwin; Chu, Maggie; De Guzman, Abner; Kim, Irene; Lim, Kathlyn; Choi, Jua; Vo, Ashley A.
Journal:
Transplantation
Issue:
Volume 104:Issue 3(2020) Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. CLAZAKIZUMAB (ANTI-IL-6) INDUCES FOXP3+ TREGS IN HIGHLY HLA SENSITIZED PATIENTS RECEIVING HLAI KIDNEY TRANSPLANTATION (NCT03380962). Issue 3 (September 2020)

Authors:
Jordan, Stanley; Ge, Shili; Ammerman, Nori; Toyoda, Mieko; Huang, Edmund; Peng, Alice; Najjar, Reiad; Sethi, Supreet; Williamson, Summer; Myers, Kate; Lim, Kathlyn; Choi, Jua; Vo, Ashley A.
Journal:
Transplantation
Issue:
Volume 104:Issue 3(2020) Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Clazakizumab for desensitization in highly sensitized patients awaiting transplantation. Issue 4 (30th December 2021)

Authors:
Vo, Ashley A.; Huang, Edmund; Ammerman, Noriko; Toyoda, Mieko; Ge, Shili; Haas, Mark; Zhang, Xiaohai; Peng, Alice; Najjar, Reiad; Williamson, Summer; Myers, Catherine; Sethi, Supreet; Lim, Kathlyn; Choi, Jua; Gillespie, Matthew; Tang, Jacqueline; Jordan, Stanley C.
Journal:
American journal of transplantation
Issue:
Volume 22:Issue 4(2022)
Page Start:
1133
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. CLAZAKIZUMAB® (ANTI-IL-6) FOR DESENSITIZATION OF HIGHLY-HLA SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT (NCT03380962). Issue 3 (September 2020)

Authors:
Vo, Ashley; Ammerman, Noriko; Huang, Edmund; Toyoda, Mieko; Ge, Shili; Peng, Alice; Najjar, Reiad; Williamson, Summer; Myers, Catherine; Sethi, Supreet; Lim, Kathlyn; Choi, Jua; Jordan, Stanley
Journal:
Transplantation
Issue:
Volume 104:Issue 3(2020) Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗